-
Revenue
$-558.78K
Net Income
-
Gross Margin
-
Op. Margin
$-631.36K
Free Cash Flow
| Breakdown | Q2 2026 (Dec 31, 2025) |
Q1 2026 (Sep 30, 2025) |
Q4 2025 (Jun 30, 2025) |
Q3 2025 (Mar 31, 2025) |
Q2 2025 (Dec 31, 2024) |
Q1 2025 (Sep 30, 2024) |
Q4 2024 (Jun 30, 2024) |
Q3 2024 (Mar 31, 2024) |
Q2 2024 (Dec 31, 2023) |
Q1 2024 (Sep 30, 2023) |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % (YoY) | nan% | nan% | nan% | nan% | nan% | nan% | nan% | nan% | nan% | nan% |
| Operating Expenses | $137.46K | $154.93K | $86.07K | $114.58K | $159.76K | $127.63K | $261.15K | $217.29K | $216.03K | $243.12K |
| Research & Development | $10.50K | $10.50K | $17.50K | - | $10.00K | $69.86K | $81.17K | $58.96K | $50.16K | $15.00K |
| Interest Expense | $12.02K | $12.05K | - | - | - | - | - | - | - | - |
| Net Income | $-149.49K | $-166.98K | $-107.47K | $-134.85K | $-159.76K | $-127.63K | $-261.15K | $-217.29K | $-216.03K | $-243.12K |
| Net Margin % | nan% | nan% | nan% | nan% | nan% | nan% | nan% | nan% | nan% | nan% |
| Diluted EPS | nan | nan | nan | -0.01 | -0.01 | nan | nan | nan | nan | nan |
| Diluted Shares Outstanding | - | - | - | 20.7M | 20.4M | - | - | - | - | - |
| Breakdown | Q2 2026 (Dec 31, 2025) |
Q1 2026 (Sep 30, 2025) |
Q4 2025 (Jun 30, 2025) |
Q3 2025 (Mar 31, 2025) |
Q2 2025 (Dec 31, 2024) |
Q1 2025 (Sep 30, 2024) |
Q4 2024 (Jun 30, 2024) |
Q3 2024 (Mar 31, 2024) |
Q2 2024 (Dec 31, 2023) |
Q1 2024 (Sep 30, 2023) |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $28.46K | $58.95K | $100.47K | $21.38K | $79.03K | $151.44K | $75.80K | $169.46K | $243.12K | $436.13K |
| Total Current Assets | $115.08K | $98.83K | $160.26K | $34.79K | $79.03K | $163.44K | $99.80K | $232.46K | $243.12K | $436.13K |
| Total Assets | $287.51K | $235.44K | $301.64K | $180.85K | $94.67K | $183.60K | $124.38K | $232.46K | $243.12K | $436.13K |
| Accounts Payable | $25.22K | $7.50K | $15.00K | $13.13K | $13.27K | $29.27K | $18.00K | $14.50K | $14.37K | $8.85K |
| Total Current Liabilities | $485.50K | $103.61K | $64.88K | $52.58K | $27.31K | $47.82K | $36.20K | $14.50K | $14.37K | $8.85K |
| Total Liabilities | $783.61K | $667.05K | $566.27K | $397.01K | $300.26K | $229.43K | $42.58K | $14.50K | $14.37K | $8.85K |
| Common Stock | $21.66K | $21.32K | $21.32K | $21.09K | $20.42K | $20.42K | $20.42K | $20.25K | $19.99K | $19.96K |
| Retained Earnings | $-1.88M | $-1.73M | $-1.56M | $-1.45M | $-1.32M | $-1.16M | $-1.03M | $-770.21K | $-552.91K | $-336.88K |
| Total Stockholders Equity | $-496.10K | $-431.61K | $-264.63K | $-216.16K | $-205.58K | $-45.83K | $81.80K | $217.96K | $228.75K | $427.28K |
| Total Liabilities & Equity | $287.51K | $235.44K | $301.64K | $180.85K | $94.67K | $183.60K | $124.38K | $232.46K | $243.12K | $436.13K |
| Breakdown | Q2 2026 (Dec 31, 2025) |
Q1 2026 (Sep 30, 2025) |
Q4 2025 (Jun 30, 2025) |
Q3 2025 (Mar 31, 2025) |
Q2 2025 (Dec 31, 2024) |
Q1 2025 (Sep 30, 2024) |
Q4 2024 (Jun 30, 2024) |
Q3 2024 (Mar 31, 2024) |
Q2 2024 (Dec 31, 2023) |
Q1 2024 (Sep 30, 2023) |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-316.47K | $-166.98K | $-107.47K | $-422.24K | $-159.76K | $-127.63K | $-261.15K | $-217.29K | $-459.15K | $-243.12K |
| Change in Payables | - | $-7.50K | - | - | - | $11.27K | $3.50K | $-14.36K | $-14.49K | $8.85K |
| Operating Cash Flow | $-132.01K | $-91.52K | $-40.91K | $-366.93K | $-261.78K | $-104.36K | $-143.65K | $-501.80K | $-323.64K | $-113.13K |
| Investing Cash Flow | - | - | $527.50K | $-47.50K | - | - | $518.80K | - | - | - |
| Stock Issued | $10.00K | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | $60.00K | $50.00K | $-407.50K | $360.00K | $265.00K | $180.00K | $50.00K | $468.80K | $364.30K | $346.80K |
SEC Filing Format - Data shown as it appears in the Q2 2026 (10-Q) filing
Period ended: Dec 31, 2025
Condensed Consolidated Statements of Operations
| Description | Dec 31, 2025 | Dec 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | - | - | - | - |
| Operating Expenses | $137.46K | - | $292.40K | - |
| Research & Development | $10.50K | - | $21.00K | - |
| Interest Expense | $12.02K | - | $24.07K | - |
| Net Income | $-149.49K | $-127.63K | $-316.47K | - |
Condensed Consolidated Balance Sheets
| Description | Dec 31, 2025 | Jun 30, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $28.46K | $100.47K |
| Total Current Assets | $115.08K | $160.26K |
| Total Assets | $287.51K | $301.64K |
| Accounts Payable | $25.22K | $15.00K |
| Total Current Liabilities | $485.50K | $64.88K |
| Total Liabilities | $783.61K | $566.27K |
| Common Stock | $21.66K | $21.32K |
| Retained Earnings | $-1.88M | $-1.56M |
| Total Stockholders Equity | $-496.10K | $-264.63K |
| Total Liabilities & Equity | $287.51K | $301.64K |
Condensed Consolidated Statements of Cash Flows
| Description | Dec 31, 2025 | Dec 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-149.49K | $-127.63K | $-316.47K | - |
| Operating Cash Flow | - | - | $-132.01K | - |
| Stock Issued | $10.00K | - | $10.00K | - |
| Financing Cash Flow | - | - | $60.00K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.